Futura Medical plc.’s (FUM) Corporate Rating Reaffirmed at N+1 Singer

N+1 Singer reissued their corporate rating on shares of Futura Medical plc. (LON:FUM) in a research report sent to investors on Thursday morning.

Shares of Futura Medical plc. (LON:FUM) traded down 1.20% during midday trading on Thursday, hitting GBX 64.22. 223,774 shares of the company’s stock were exchanged. The company has a 50-day moving average of GBX 57.33 and a 200-day moving average of GBX 29.57. Futura Medical plc. has a 52 week low of GBX 14.31 and a 52 week high of GBX 95.60. The firm’s market cap is GBX 63.64 million.

About Futura Medical plc.

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.

Receive News & Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.